Andrew N Schiff's Net Worth
Estimate Recalculated Nov 7, 2024 04:51PM EST
Who is Andrew N Schiff
Andrew N Schiff has an estimated net worth of $2.09 Million. This is based on reported shares across multiple companies, which include Zeltiq Aesthetics Inc, CEMPRA, INC., Aclaris Therapeutics, Inc., Monte Rosa Therapeutics, Inc., ViewRay, Inc., Zosano Pharma Corp, Esperion Therapeutics, Inc., ADMA BIOLOGICS, INC., Loxo Oncology, Inc., AGILE THERAPEUTICS INC, Elevation Oncology, Inc., Syros Pharmaceuticals, Inc., Cidara Therapeutics, Inc., T2 Biosystems, Inc., SafeStitch Medical, Inc., SUNESIS PHARMACEUTICALS INC, Durata Therapeutics, Inc., Versartis, Inc., MYOGEN INC, Sirion Holdings, Inc., Adams Respiratory Therapeutics, Inc., BARRIER THERAPEUTICS INC, INTERPHARM HOLDINGS INC, and PLANET TECHNOLOGIES, INC.
SEC CIK
Andrew N Schiff's CIK is 0001172252
Past Insider Trading and Trends
2014 was Andrew N Schiff's most active year for acquiring shares with 9 total transactions. Andrew N Schiff's most active month to acquire stocks was the month of May. 2015 was Andrew N Schiff's most active year for disposing of shares, totalling 6 transactions. Andrew N Schiff's most active month to dispose stocks was the month of November. 2021 saw Andrew N Schiff paying a total of $0.00 for 62,738 shares, this is the most they've acquired in one year. In 2014 Andrew N Schiff cashed out on 39,880 shares for a total of $792,970.75, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
